Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

被引：0
作者：
Nobuyuki Amemiya
Takashi Takei
Chiari Kojima
Hirohiko Nokiba
Mitsuyo Itabashi
Kosaku Nitta
机构：
[1] Tokyo Women’s Medical University,Department of Medicine, Kidney Center
来源：
Clinical and Experimental Nephrology | 2011年 / 15卷
关键词：
Frequently relapsing minimal change nephrotic syndrome; Rituximab; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment with a single dose of rituximab alone induced remission in a patient with relapsed minimal change nephrotic syndrome (MCNS). A 27-year-old man was given corticosteroid (prednisolone; PSL) and cyclosporine (CyA) therapy combined with rituximab for his fifth relapse in 2008. Thereafter, complete remission was achieved and maintained despite eventual discontinuation of the PSL and CyA. In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS.
引用
收藏
页码：933 / 936
页数：3
相关论文
共 50 条
[41]   Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease [J].
Haddad, Maha ;
Kale, Arundhati ;
Butani, Lavjay .
BMC NEPHROLOGY, 2021, 22 (01)
[42]   Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury [J].
Ashikaga, Eijin ;
Uda, Susumu ;
Kamata, Kazuhisa ;
Shikida, Yasuto ;
Inoue, Takashi ;
Kuno, Yoshihiro ;
Yao, Atsushi ;
Nakamura, Mari ;
Kai, Keiko .
CEN CASE REPORTS, 2016, 5 (01) :56-60
[43]   Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury [J].
Eijin Ashikaga ;
Susumu Uda ;
Kazuhisa Kamata ;
Yasuto Shikida ;
Takashi Inoue ;
Yoshihiro Kuno ;
Atsushi Yao ;
Mari Nakamura ;
Keiko Kai .
CEN Case Reports, 2016, 5 (1) :56-60
[44]   Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura [J].
Nishikawa, Mana ;
Shimada, Noriaki ;
Kawazoe, Tomohiro ;
Sawaki, Ryo ;
Ikuta, Haruka ;
Kanzaki, Motoko ;
Fukuoka, Kosuke ;
Fukushima, Masaki ;
Asano, Kenichiro .
INTERNAL MEDICINE, 2020, 59 (07) :983-986
[45]   Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type [J].
Chaudhuri, Abanti ;
Kambham, Neeraja ;
Sutherland, Scott ;
Grimm, Paul ;
Alexander, Steven ;
Concepcion, Waldo ;
Sarwal, Minnie ;
Wong, Cynthia .
PEDIATRIC TRANSPLANTATION, 2012, 16 (05) :E183-E187
[46]   Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome [J].
Nozu, K ;
Iijima, K ;
Fujisawa, M ;
Nakagawa, A ;
Yoshikawa, N ;
Matsuo, M .
PEDIATRIC NEPHROLOGY, 2005, 20 (11) :1660-1663
[47]   Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab [J].
Megha Suri ;
Kim Tran ;
Ajay P. Sharma ;
Guido Filler ;
Joanne Grimmer .
International Urology and Nephrology, 2008, 40 :807-810
[48]   Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab [J].
Suri, Megha ;
Tran, Kim ;
Sharma, Ajay P. ;
Filler, Guido ;
Grimmer, Joanne .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (03) :807-810
[49]   Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome [J].
Kandai Nozu ;
Kazumoto Iijima ;
Masato Fujisawa ;
Atsuko Nakagawa ;
Norishige Yoshikawa ;
Masafumi Matsuo .
Pediatric Nephrology, 2005, 20 :1660-1663
[50]   Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy [J].
Kerstin Benz ;
Jörg Dötsch ;
Wolfgang Rascher ;
Daniel Stachel .
Pediatric Nephrology, 2004, 19 :794-797
12345